摘要
全世界炎症性眼病的发病率都在增加。据报道,几种失调的炎症途径,包括NOD样受体蛋白3(NLRP3)炎性小体,对眼科疾病的发病机制和进展有显著贡献。虽然现有的对抗疗法/传统药物已被证明在管理眼部疾病方面是有效的,但全球对替代疗法的持续需求,这些疗法具有最小的药物不良反应,易于获得,患者依从性提高和更好的疾病结果。因此,一些研究正在研究天然产物和草药配方在阻挠炎症途径(包括NLRP3炎症小体)中的利用,以预防或管理眼部疾病。在本综述中,我们重点介绍了最近报道的炎症途径,特别强调了参与眼部疾病发展的NLRP3炎症小体。此外,我们提出了各种天然产物和植物化学物质,据报道它们会干扰这些途径及其潜在的作用机制。这些天然产品代表了治疗几种炎症性眼病的潜在治疗应用。
关键词: 炎症,眼病,NLRP3炎症小体,治疗,天然产物,BRB。
Current Medicinal Chemistry
Title:Therapeutic Targeting of Inflammatory Pathways with Emphasis on NLRP3 Inflammasomes by Natural Products: A Novel Approach for the Treatment of Inflammatory Eye Diseases
Volume: 29 Issue: 16
关键词: 炎症,眼病,NLRP3炎症小体,治疗,天然产物,BRB。
摘要: There is an increase in the incidence of inflammatory eye diseases worldwide. Several dysregulated inflammatory pathways, including the NOD-like receptor protein 3 (NLRP3) inflammasome, have been reported to contribute significantly to the pathogenesis and progression of ophthalmic diseases. Although the available allopathic/ conventional medicine has demonstrated effectiveness in managing eye diseases, there is an ongoing global demand for alternative therapeutics with minimal adverse drug reactions, easy availability, increase in patient compliance, and better disease outcomes. Therefore, several studies are investigating the utilization of natural products and herbal formulations in impeding inflammatory pathways, including the NLRP3 inflammasome, in order to prevent or manage eye diseases. In the present review, we highlight the recently reported inflammatory pathways with special emphasis on NLRP3 Inflammasomes involved in the development of eye diseases. Furthermore, we present a variety of natural products and phytochemicals that were reported to interfere with these pathways and their underlying mechanisms of action. These natural products represent potential therapeutic applications for the treatment of several inflammatory eye diseases.
Export Options
About this article
Cite this article as:
Therapeutic Targeting of Inflammatory Pathways with Emphasis on NLRP3 Inflammasomes by Natural Products: A Novel Approach for the Treatment of Inflammatory Eye Diseases, Current Medicinal Chemistry 2022; 29 (16) . https://dx.doi.org/10.2174/0929867328666210910154330
DOI https://dx.doi.org/10.2174/0929867328666210910154330 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements